January 13, 2025 - 02:56
ALAMEDA, Calif., January 12, 2025—Exelixis, Inc. has announced its preliminary unaudited financial results for the fiscal year 2024, alongside financial guidance for the upcoming fiscal year 2025. The company is optimistic about the potential for significant advancements in clinical and regulatory efforts, particularly concerning its cabozantinib franchise.
In 2025, Exelixis plans to focus on executing its clinical programs and anticipates multiple data readouts for zanzalintinib, as well as developments across its diverse pipeline of small molecules and biotherapeutics. The company aims to leverage its existing assets while exploring new opportunities to enhance its market position.
With a clear strategy in place, Exelixis is poised for a year of growth, innovation, and impactful milestones that could shape the future of its therapeutic offerings. The commitment to advancing patient care remains at the forefront of Exelixis's mission as it navigates the challenges and opportunities ahead.
August 9, 2025 - 02:50
Rising College Endowment Taxes Prompt Financial ConcernsTop universities such as Harvard, Yale, and Stanford are facing significant financial challenges due to new tax regulations on college endowments. These prestigious institutions are now required to...
August 8, 2025 - 03:20
Exploring the Financial Impact of Design in ArchitectureA new book titled “Value of Design” pays homage to the late MIT research scientist Andrea Chegut, whose groundbreaking work connected the dots between the economics of innovation and the realms...
August 7, 2025 - 10:40
US Stock Futures Experience Fluctuations as Trade Deadline ApproachesUS stock futures wavered above the flatline as the deadline for President Trump`s trade negotiations draws near. Investors are closely monitoring developments, as uncertainty surrounding trade...
August 6, 2025 - 22:47
Financial Professionals Gain Insights on Digital Lending and ComplianceA recent survey has revealed valuable insights for financial professionals regarding digital lending and compliance. The findings highlight the growing importance of digital signatures in...